Exploring the sequence features determining amyloidosis in human antibody light chains

Abstract The light chain (AL) amyloidosis is caused by the aggregation of light chain of antibodies into amyloid fibrils. There are plenty of computational resources available for the prediction of short aggregation-prone regions within proteins. However, it is still a challenging task to predict th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Puneet Rawat, R. Prabakaran, Sandeep Kumar, M. Michael Gromiha
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/4fa62a20ac6040f6894d6f47565edcc3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4fa62a20ac6040f6894d6f47565edcc3
record_format dspace
spelling oai:doaj.org-article:4fa62a20ac6040f6894d6f47565edcc32021-12-02T14:33:57ZExploring the sequence features determining amyloidosis in human antibody light chains10.1038/s41598-021-93019-92045-2322https://doaj.org/article/4fa62a20ac6040f6894d6f47565edcc32021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-93019-9https://doaj.org/toc/2045-2322Abstract The light chain (AL) amyloidosis is caused by the aggregation of light chain of antibodies into amyloid fibrils. There are plenty of computational resources available for the prediction of short aggregation-prone regions within proteins. However, it is still a challenging task to predict the amyloidogenic nature of the whole protein using sequence/structure information. In the case of antibody light chains, common architecture and known binding sites can provide vital information for the prediction of amyloidogenicity at physiological conditions. Here, in this work, we have compared classical sequence-based, aggregation-related features (such as hydrophobicity, presence of gatekeeper residues, disorderness, β-propensity, etc.) calculated for the CDR, FR or VL regions of amyloidogenic and non-amyloidogenic antibody light chains and implemented the insights gained in a machine learning-based webserver called “VLAmY-Pred” ( https://web.iitm.ac.in/bioinfo2/vlamy-pred/ ). The model shows prediction accuracy of 79.7% (sensitivity: 78.7% and specificity: 79.9%) with a ROC value of 0.88 on a dataset of 1828 variable region sequences of the antibody light chains. This model will be helpful towards improved prognosis for patients that may likely suffer from diseases caused by light chain amyloidosis, understanding origins of aggregation in antibody-based biotherapeutics, large-scale in-silico analysis of antibody sequences generated by next generation sequencing, and finally towards rational engineering of aggregation resistant antibodies.Puneet RawatR. PrabakaranSandeep KumarM. Michael GromihaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Puneet Rawat
R. Prabakaran
Sandeep Kumar
M. Michael Gromiha
Exploring the sequence features determining amyloidosis in human antibody light chains
description Abstract The light chain (AL) amyloidosis is caused by the aggregation of light chain of antibodies into amyloid fibrils. There are plenty of computational resources available for the prediction of short aggregation-prone regions within proteins. However, it is still a challenging task to predict the amyloidogenic nature of the whole protein using sequence/structure information. In the case of antibody light chains, common architecture and known binding sites can provide vital information for the prediction of amyloidogenicity at physiological conditions. Here, in this work, we have compared classical sequence-based, aggregation-related features (such as hydrophobicity, presence of gatekeeper residues, disorderness, β-propensity, etc.) calculated for the CDR, FR or VL regions of amyloidogenic and non-amyloidogenic antibody light chains and implemented the insights gained in a machine learning-based webserver called “VLAmY-Pred” ( https://web.iitm.ac.in/bioinfo2/vlamy-pred/ ). The model shows prediction accuracy of 79.7% (sensitivity: 78.7% and specificity: 79.9%) with a ROC value of 0.88 on a dataset of 1828 variable region sequences of the antibody light chains. This model will be helpful towards improved prognosis for patients that may likely suffer from diseases caused by light chain amyloidosis, understanding origins of aggregation in antibody-based biotherapeutics, large-scale in-silico analysis of antibody sequences generated by next generation sequencing, and finally towards rational engineering of aggregation resistant antibodies.
format article
author Puneet Rawat
R. Prabakaran
Sandeep Kumar
M. Michael Gromiha
author_facet Puneet Rawat
R. Prabakaran
Sandeep Kumar
M. Michael Gromiha
author_sort Puneet Rawat
title Exploring the sequence features determining amyloidosis in human antibody light chains
title_short Exploring the sequence features determining amyloidosis in human antibody light chains
title_full Exploring the sequence features determining amyloidosis in human antibody light chains
title_fullStr Exploring the sequence features determining amyloidosis in human antibody light chains
title_full_unstemmed Exploring the sequence features determining amyloidosis in human antibody light chains
title_sort exploring the sequence features determining amyloidosis in human antibody light chains
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/4fa62a20ac6040f6894d6f47565edcc3
work_keys_str_mv AT puneetrawat exploringthesequencefeaturesdeterminingamyloidosisinhumanantibodylightchains
AT rprabakaran exploringthesequencefeaturesdeterminingamyloidosisinhumanantibodylightchains
AT sandeepkumar exploringthesequencefeaturesdeterminingamyloidosisinhumanantibodylightchains
AT mmichaelgromiha exploringthesequencefeaturesdeterminingamyloidosisinhumanantibodylightchains
_version_ 1718391126764814336